Journal article

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2(Front. Immunol., (2022), 13, (889372), 10.3389/fimmu.2022.889372)

BD Wines, L Kurtovic, HM Trist, S Esparon, E Lopez, K Chappin, LJ Chan, FL Mordant, WS Lee, NA Gherardin, SK Patel, GE Hartley, P Pymm, JP Cooney, JG Beeson, DI Godfrey, LM Burrell, MC van Zelm, AK Wheatley, AW Chung Show all

Frontiers in Immunology | FRONTIERS MEDIA SA | Published : 2023

Abstract

In the published article, there was an error in the legend for Figure 3 as published. The statistics style output rather than the significance levels was reported. The corrected legend appears below. “Characterization of engineered human flACE2-Fc and trACE2–Fc fusion proteins. (A) Size-exclusion chromatography (SEC) of IEX fractions containing flACE2-Fc-WT using a Superose 6 column, with oligomeric, monomeric forms and low mw impurities (†) indicated; and (B) SEC of IEX fractions containing flACE2-Fc H429Y, showing the high proportion of oligomeric species. (C–F) Biolayer interferometry (BLI) analysis of ACE2-Fc proteins which were immobilized on anti-human Fc (BLI) sensors and reacted with..

View full abstract